A study of the oxidation-induced conformational and functional changes in neuroserpin

Iranian Biomedical Journal

Volumn 11, Issue 1, 2007, Pages 41-46

  Mohsenifar, Afshin ^a   Lotfi, Abbas S ^a   Ranjbar, Bijan ^a   Allameh, Abdolamir ^a   Zaker, Farhad ^b   Hasani, Leila ^a   Kia, Batool Etemadi ^a   Hasannia, Sadegh ^a,c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF GUILAN   (Iran)

Author keywords

Conformational disorder; Inhibitory activity; Neuroserpin; Reactive oxygen species; Surface hydrophobicity

Indexed keywords

2,4 DINITROPHENYLHYDRAZINE; 8 ANILINO 1 NAPHTHALENESULFONIC ACID; COMPLEMENTARY DNA; NEUROSERPIN; NICKEL SULFATE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG CONFORMATION; DRUG MECHANISM; DRUG OXIDATION; DRUG PURIFICATION; ENZYME INHIBITION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION;

ESCHERICHIA COLI; HUMANS; HYDROPHOBICITY; NEUROPEPTIDES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CONFORMATION; PROTEIN FOLDING; RECOMBINANT PROTEINS; SERPINS; SPECTROMETRY, FLUORESCENCE;

EID: 33847067475     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Osterwalder, T., Contartese, J., Stoeckli, E.T., Kuhn, T.B. and Sonderegger, P. (1996) Neuroserpin, an axonally secreted serine protease inhibitor. EMBO J. 15: 2944-2953.
2. Schrimpf, S.P., Bleiker, A.J., Brecevic, L., Kozlov, S.V., Berger, P., Osterwalder, T., Krueger, S.R., Schinzel, A., and Sonderegger, P. (1997) Human neuroserpin (PI12): cDNA cloning and chromosomal localization to 3q26. Genomics 40: 55-62.
3. Krueger, S.R., Ghisu, G.P., Cinelli, P., Gschwend, T.P., Osterwalder, T., Wolfer, D.P. and Sonderegger, P. (1997) Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse. J. Neurosci. 17: 8984-8996.
4. Irving, J.A., Pike, R.N., Lesk, A.M. and Whisstock, J.C. (2000) Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res. 10: 1845-1864.
5. Whisstock, J., Skinner, R. and Lesk, A.M. (1998) An atlas of serpin conformations. Trends Biochem. Sci. 23: 63-67.
6. Cinelli, P., Madani, R., Tsuzuki, N., Vallet, P., Arras, M., Zhao, C.N., Osterwalder, T., Rulicke, T. and Sonderegger, P. (2001) Neuroserpin, a neuroprotective factor in focal ischemic stroke. Mol. Cell Neurosci. 18: 443-457.
7. Hastings, G.A., Coleman, T.A., Haudenschild, C.C., Stefansson, S., Smith, E.P., Barthlow, R., Cherry, S., Sandkvist, M. and Lawrence, D.A. (1997) Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J. Biol. Chem. 272: 33062-33067.
8. Osterwalder, T., Cinelli, P., Baici, A., Pennella, A., Krueger, S.R., Schrimpf, S.P., Meins, M. and Sonderegger, P. (1998) The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin. J. Biol. Chem. 273: 2312-2321.
9. Davis, R.L., Shrimpton, A.E., Holohan, P.D., Bradshaw, C., Felglin, D., Collins, H.G., Sonderegger, P., Kinter, J., Becker, L.M., Lacbawan, F., Krasnewich, D., Muenke, M., Lawrence, D.A., Yerby, M.S., Shaw, C.M., Gooptu, B., Elliott, P.R., Finch, J.T., Carrell, R.W. and Lomas, D.A. (1999) Familial dementia caused by polymerization of mutant neuroserpin. Nature 401: 376-379.
10. Loebermann, H., Tokuoka, R., Deisenhofer, J. and Huber, R. (1984) Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J. Mol. Biol. 177: 531-557.
11. Butterfield, D.A. and Stadtman, E.R. (1997) Protein oxidation processes in aging brain. Adv. Cell Aging Gerontol. 2: 161-191.
12. Dean, R.T., Fu, S., Stocker, R. and Davis, M.J. (1997) Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 324: 1-18.
13. Forster, M.J., Dubey, A., Dawson, K.M., Stutts, W.A., Lal, H. and Sohal, R.S. (1996) Age-related losses of cognitive function and motor skills in mice associated with oxidative protein damage in the brain. Proc. Natl. Acad. Sci. USA 93: 4765-4769.
14. Aksenov, M.Y., Aksenova, M.V., Butterfield, D.A., Geddes, J.W. and Markesbery, W.R. (2001) Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103 (2): 373-383.
15. Varadarajan, S., Yatin, S., Aksenova, M. and Butterfield, D.A. (2000) Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 130 (2-3): 184-208.
16. Belorgey, D., Crowther, D.C., Mahadeva, R. and Lomas, D.A. (2002) Mutant neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro. J. Biol. Chem. 277 (19): 17367-17373.
17. Schagger, H. and von Jagow, G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368-379.
18. Boyer, R.F. (1986) Modern Experimental Biochemistry. The Benyamin/Cummings Publishing Company, INC, Menlo Park, California, USA.
19. Floor, E. and Wetzel, M.G. (1998) Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem. 70 (1): 268-275.
20. Smith, C.D., Carney, J.M., Starke-Reed, P.E., Oliver, C.N., Stadtman, E.R., Floyd, R.A. and Marksbery, W.R. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88: 10540-10543.
21. Levine, R.L., Garland, D., Oliver, C.N., Amici, A., Climent, I., Lenz, A.G., Ahn, B.W., Shaltiel, S. and Stadtman, E.R. (1990) Determination of carbonyl content in Oxidatively modified protein. Methods Enzymol. 186: 464-478.
22. Krueger, S.R., Ghisu, G.P., Cinelli, P., Gschwend, T.P., Osterwalder, T., Wolfer, D.P. and Sonderegger, P. (1997) Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse. J. Neurosci. 17 (23): 8984-8996.
23. Pallares, I., Vendrell, J., Aviles, F.X. and Ventura, S. (2004) Amyloid fibril formation by a partially structured intermediate state of α-chymotrypsin. J. Mol. Biol. 342: 321-331.
24. Leinonen, J.S., Ahonen, J.P., Lonnrot, K., Jehkonen, M., Dastidar, P., Molnar, G. and Alho, H. (2000) Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke 31: 33-39.
25. Yepes, M., Sandkvist, M., Wong, M.K.K., Coleman, T.A., Smith, E., Cohan, S.L. and Lawrence, D.A. (2000) Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 96 (2): 569-576.
26. Cinelli, P., Madani, R., Tsuzuki, N., Vallet, P., Arras, M., Zhao, C.N., Osterwalder, T., Rulicke, T. and Sonderegger, P. (2001) Neuroserpin, a neuroprotective factor in focal ischemic stroke. Mol. Cell Neurosci. 18: 443-457.
27. Berlett, B.S. and Stadtman, E.R. (1997) Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272 (33): 20313-20316.
28. Swaim, M.W. and Pizzo, S.V. (1988) Modification of the tandem reactive centres of human inter-alpha-trypsin inhibitor with butanedione and cisdichlorodiammineplatinum (II). J. Leukocyte Biol. 43: 365-379.
29. Levine, R.L., Mosoni, L., Berlett, B.S. and Stadtman, E.R. (1996) Methionine residues as endogenous antioxidants in proteins. Proc. Natl. Acad. Sci. USA 93: 15036-15040.
30. Griffiths, S.W. and Cooney, C.L. (2002) Relationship between protein structure and methionine oxidation in recombinant human α1-antitrypsin. Biochemistry 41 (20): 6245-6252.
31. Taggart, C., Cervantes-Laurean, D., Kim, G., McElvaney, N., Wehr, N., Moss, J. and Levine, R.L. (2000) Oxidation of either methionine 351 or methionine 358 in α1-antitrypsin causes loss of antineutrophil elastase activity. J. Biol. Chemist. 275 (35): 27258-27265.